Industrial animal agriculture has relied extensively on the use of an antibiotic unused in human medicine, but new research ...

Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the United States Patent and Trademark ...

Wockhardt is advancing Zaynich, a novel antibiotic combination, targeting drug-resistant infections, with plans for regulatory submissions in the US and India. The company is exploring out-licensing ...

Gram-negative bacteria develop resistance to commonly prescribed antibiotics through ... Antibiotic treatment guidelines consistently recommended empiric therapy upon patient presentation ...

Dr. Jennifer Schneider discusses Centauri Therapeutics' novel approach to combating Gram-negative infections, its first ...

Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...

Findings show imported seafood as a potential source of colistin-resistance genes, underscoring the urgency of addressing ...

A new study by researchers from the University of Georgia has uncovered a troubling pathway for the spread of antibiotic ...

Colistin, a last-resort antibiotic, is losing its power due to rising resistance—and the culprits might be hiding in your ...

Colistin is a potent, last-resort antibiotic, used only to treat people with dangerous, life-threatening bacterial infections ...

A team of US researchers on Sunday said it has identified a way that colistin (a potent, last-resort antibiotic) resistance ...